(WJET) – A pharmaceutical corporation has issued a nationwide voluntary recall of its epinephrine syringes. Adamis Pharmaceuticals Corporation issued the voluntary recall of its SYMJEPI (epinephrine) ...
Adamis Pharmaceuticals recalled four lots of SYMJEPI (epinephrine) Injection Pre-Filled Single-Dose Syringes because a needle-clogging problem could occur when the epinephrine is needed to save a life ...
The Food and Drug Administration has granted Amphastar approval for epinephrine injection, 1 mg/10 ml (0.1 mg/ml) single dose pre-filled syringe. Epinephrine injection is indicated to increase mean ...
Some lots of the SYMJEPI epinephrine syringes used for emergency treatment of allergic reactions have been recalled because the needle may clog. Adamis Pharmaceuticals Corp. has recalled some 0.15 mg ...
A timely injection of epinephrine can save the life of a person experiencing an allergic reaction. But what if the syringe is jammed? Now, a U.S. company is recalling its version of the critical ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 16, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's New Drug ...
The pharmacodynamics profile for 13.2-mg IN epinephrine in the opposite or same nostrils was comparable to that of the 0.3-mg autoinjector and 0.5-mg manual syringe. Intranasal (IN) epinephrine is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results